Cargando…

International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis

INTRODUCTION: An international cohort study of 73 anti-Ku-positive patients with different connective tissue diseases was conducted to differentiate the anti-Ku-positive populations of patients based on their autoantibody profile and clinical signs/symptoms and to establish possible correlations bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakota, Katja, Thallinger, Gerhard G, Sodin-Semrl, Snezna, Rozman, Blaz, Ambrozic, Ales, Tomsic, Matija, Praprotnik, Sonja, Cucnik, Sasa, Mrak-Poljsak, Katjusa, Ceribelli, Angela, Cavazzana, Ilaria, Franceschini, Franco, Vencovsky, Jiri, Czirják, Laszlo, Varjú, Cecilia, Steiner, Gunther, Aringer, Martin, Stamenkovic, Bojana, Distler, Oliver, Matucci-Cerinic, Marco, Kveder, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392788/
https://www.ncbi.nlm.nih.gov/pubmed/22226402
http://dx.doi.org/10.1186/ar3550
_version_ 1782237645456277504
author Lakota, Katja
Thallinger, Gerhard G
Sodin-Semrl, Snezna
Rozman, Blaz
Ambrozic, Ales
Tomsic, Matija
Praprotnik, Sonja
Cucnik, Sasa
Mrak-Poljsak, Katjusa
Ceribelli, Angela
Cavazzana, Ilaria
Franceschini, Franco
Vencovsky, Jiri
Czirják, Laszlo
Varjú, Cecilia
Steiner, Gunther
Aringer, Martin
Stamenkovic, Bojana
Distler, Oliver
Matucci-Cerinic, Marco
Kveder, Tanja
author_facet Lakota, Katja
Thallinger, Gerhard G
Sodin-Semrl, Snezna
Rozman, Blaz
Ambrozic, Ales
Tomsic, Matija
Praprotnik, Sonja
Cucnik, Sasa
Mrak-Poljsak, Katjusa
Ceribelli, Angela
Cavazzana, Ilaria
Franceschini, Franco
Vencovsky, Jiri
Czirják, Laszlo
Varjú, Cecilia
Steiner, Gunther
Aringer, Martin
Stamenkovic, Bojana
Distler, Oliver
Matucci-Cerinic, Marco
Kveder, Tanja
author_sort Lakota, Katja
collection PubMed
description INTRODUCTION: An international cohort study of 73 anti-Ku-positive patients with different connective tissue diseases was conducted to differentiate the anti-Ku-positive populations of patients based on their autoantibody profile and clinical signs/symptoms and to establish possible correlations between antibodies against Ku p70 and Ku p80 with autoimmune diseases. METHODS: Sera of anti-Ku-positive patients were collected from six European centers and were all secondarily tested (in the reference center); 73 were confirmed as positive. Anti-Ku antibodies were detected with counter-immunoelectrophoresis (CIE), line immunoassay (LIA), and immunoblot analyses. All clinical and laboratory data were follow-up cumulative data, except for anti-Ku antibodies. Statistical analyses were performed by using R (V 2.12.1). The Fisher Exact test was used to evaluate the association between anti-Ku antibodies and diagnosis, gender, clinical signs, and other observed antibodies. The P values were adjusted for multiple testing. Separation of disease populations based on the presence of antibodies and clinical signs was investigated by principal-components analysis, which was performed by using thr// R's prcomp function with standard parameters. RESULTS: A 16% higher prevalence of anti-Ku p70 was found over anti-Ku p80 antibodies. In 41 (57%) patients, a combination of both was detected. Five (7%) patients, who were CIE and/or LIA anti-Ku positive, were negative for both subsets, as detected with the immunoblot; 31% of the patients had undifferentiated connective tissue disease (UCTD); 29% had systemic sclerosis (SSc); 18% had systemic lupus erythematosus (SLE); 11% had rheumatoid arthritis; 7% had polymyositis; and 3% had Sjögren syndrome. CONCLUSIONS: A significant positive association was found between female patients with anti-Ku p70 and joint/bone features, and a significant negative association was found between female patients with anti-Ku p80 only and joint/bone features (P = 0.05, respectively). By using the first and the third components of the principal-component analysis (PCA) with 29 parameters evaluated, we observed that the anti-Ku-positive population of UCTD patients had overlapping parameters, especially with SLE, as opposed to SSc, which could be helpful in delineating UCTD patients.
format Online
Article
Text
id pubmed-3392788
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33927882012-07-11 International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis Lakota, Katja Thallinger, Gerhard G Sodin-Semrl, Snezna Rozman, Blaz Ambrozic, Ales Tomsic, Matija Praprotnik, Sonja Cucnik, Sasa Mrak-Poljsak, Katjusa Ceribelli, Angela Cavazzana, Ilaria Franceschini, Franco Vencovsky, Jiri Czirják, Laszlo Varjú, Cecilia Steiner, Gunther Aringer, Martin Stamenkovic, Bojana Distler, Oliver Matucci-Cerinic, Marco Kveder, Tanja Arthritis Res Ther Research Article INTRODUCTION: An international cohort study of 73 anti-Ku-positive patients with different connective tissue diseases was conducted to differentiate the anti-Ku-positive populations of patients based on their autoantibody profile and clinical signs/symptoms and to establish possible correlations between antibodies against Ku p70 and Ku p80 with autoimmune diseases. METHODS: Sera of anti-Ku-positive patients were collected from six European centers and were all secondarily tested (in the reference center); 73 were confirmed as positive. Anti-Ku antibodies were detected with counter-immunoelectrophoresis (CIE), line immunoassay (LIA), and immunoblot analyses. All clinical and laboratory data were follow-up cumulative data, except for anti-Ku antibodies. Statistical analyses were performed by using R (V 2.12.1). The Fisher Exact test was used to evaluate the association between anti-Ku antibodies and diagnosis, gender, clinical signs, and other observed antibodies. The P values were adjusted for multiple testing. Separation of disease populations based on the presence of antibodies and clinical signs was investigated by principal-components analysis, which was performed by using thr// R's prcomp function with standard parameters. RESULTS: A 16% higher prevalence of anti-Ku p70 was found over anti-Ku p80 antibodies. In 41 (57%) patients, a combination of both was detected. Five (7%) patients, who were CIE and/or LIA anti-Ku positive, were negative for both subsets, as detected with the immunoblot; 31% of the patients had undifferentiated connective tissue disease (UCTD); 29% had systemic sclerosis (SSc); 18% had systemic lupus erythematosus (SLE); 11% had rheumatoid arthritis; 7% had polymyositis; and 3% had Sjögren syndrome. CONCLUSIONS: A significant positive association was found between female patients with anti-Ku p70 and joint/bone features, and a significant negative association was found between female patients with anti-Ku p80 only and joint/bone features (P = 0.05, respectively). By using the first and the third components of the principal-component analysis (PCA) with 29 parameters evaluated, we observed that the anti-Ku-positive population of UCTD patients had overlapping parameters, especially with SLE, as opposed to SSc, which could be helpful in delineating UCTD patients. BioMed Central 2012 2012-01-06 /pmc/articles/PMC3392788/ /pubmed/22226402 http://dx.doi.org/10.1186/ar3550 Text en Copyright ©2012 Lakota et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lakota, Katja
Thallinger, Gerhard G
Sodin-Semrl, Snezna
Rozman, Blaz
Ambrozic, Ales
Tomsic, Matija
Praprotnik, Sonja
Cucnik, Sasa
Mrak-Poljsak, Katjusa
Ceribelli, Angela
Cavazzana, Ilaria
Franceschini, Franco
Vencovsky, Jiri
Czirják, Laszlo
Varjú, Cecilia
Steiner, Gunther
Aringer, Martin
Stamenkovic, Bojana
Distler, Oliver
Matucci-Cerinic, Marco
Kveder, Tanja
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis
title International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis
title_full International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis
title_fullStr International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis
title_full_unstemmed International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis
title_short International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis
title_sort international cohort study of 73 anti-ku-positive patients: association of p70/p80 anti-ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392788/
https://www.ncbi.nlm.nih.gov/pubmed/22226402
http://dx.doi.org/10.1186/ar3550
work_keys_str_mv AT lakotakatja internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT thallingergerhardg internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT sodinsemrlsnezna internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT rozmanblaz internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT ambrozicales internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT tomsicmatija internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT praprotniksonja internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT cucniksasa internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT mrakpoljsakkatjusa internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT ceribelliangela internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT cavazzanailaria internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT franceschinifranco internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT vencovskyjiri internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT czirjaklaszlo internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT varjucecilia internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT steinergunther internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT aringermartin internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT stamenkovicbojana internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT distleroliver internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT matuccicerinicmarco internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis
AT kvedertanja internationalcohortstudyof73antikupositivepatientsassociationofp70p80antikuantibodieswithjointbonefeaturesanddifferentiationofdiseasepopulationsbyusingprincipalcomponentsanalysis